Drug Trial Radar · NCT00175838
Primary Thrombocythaemia 1 Trial
Last checked: Nov 19, 2026Latest source record: Jan 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,398
Actual
Start
Jul 1997
Primary completion
Nov 2016
Study completion Nov 2016
Sponsor
- Lead sponsor
- University of CambridgeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Cambridge University Hospitals NHS Foundation Trust; Institute of Cancer Research, United Kingdom
- First posted
- Sep 15, 2005
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 59 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
Conditions
- Thrombocythemia
- Myeloproliferative Disorder
Interventions
HydroxyureaDrug
Hydroxyurea (or hydroxycarbamide) is an antineoplastic drug commonly used to treat haematological malignancies.
AspirinDrug
Aspirin is an anti-aggregating agent, and has been shown to reduce/alleviate minor ischaemic symptoms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Does hydroxyurea reduce thrombosis and major haemorrhage when added to aspirin?Time frame: 14 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Addenbrooke's Hospital
Cambridge, Cambs, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.